The role of SIX6 gene in juvenile open-angle glaucoma: a subtle contributor to the mutational landscape
- PMID: 40576883
- DOI: 10.1007/s10384-025-01233-z
The role of SIX6 gene in juvenile open-angle glaucoma: a subtle contributor to the mutational landscape
Abstract
Purpose: Juvenile onset open-angle glaucoma (JOAG) typically affects individuals under 40 years of age, causing a rise in intraocular pressure that results in considerable damage to the optic nerve. To expand the spectrum of mutations linked to JOAG and explore their structural consequences, we examined the genetic alterations within the SIX6 gene.
Study design: We focused on assessing the whole coding region of the SIX6 gene and the clinical significance of the common SIX6 gene single nucleotide polymorphisms (SNP) rs10483727 and rs33912345, specifically analyzing its association with key clinical factors, including intraocular pressure (IOP), visual acuity, and the vertical cup-to-disc ratio (VCDR).
Method: The study included 111 unrelated patients with confirmed JOAG and 100 healthy adult controls without any ocular or systemic conditions. The patients initially underwent genetic screening for pathogenic variants in the CYP1B1, MYOC, and OPTN genes. Individuals who tested negative for pathogenic variants in these three genes (n=81) were subsequently screened for variants in the SIX6 gene while all 111 patients and 100 control samples were screened for SNPs to strengthen the statistical correlation. Identified sequence variations were searched in the ClinVar databases, HGMD, and dbSNP. Six different online available algorithms including REVEL, SIFT, CADD, Mutation Taster, IMutant2.0, and MetaLR were used for the pathogenicity prediction of missense variations. The Structural consequences of detected possible pathogenic variations were predicted by using PyMol, Chimera and molecular dynamics (MD) simulation of these changes. Statistical analyses assessed the association of rs33912345 with disease phenotypes.
Results: Sanger sequencing identified seven nucleotide variants in the SIX6 gene, including five missense and two synonymous variants. Two missense variants, p.(A99G) and p.(S156R), were predicted to be pathogenic. The novel variant p.(A99G) was absent in controls and demonstrated significant structural disruption, with altered intramolecular interactions and steric clashes. Homology analysis revealed high evolutionary conservation at the mutated positions, highlighting their functional significance. MD simulations confirmed altered stability in the mutant proteins. Logistic regression linked rs33912345 to JOAG, with significant associations observed for IOP (p = 0.01538), and VCDR (p = 0.019).
Conclusion: This study identified novel and known pathogenic variants in the SIX6 gene that may contribute to JOAG pathogenesis. Structural and functional analyses suggest that these mutations disrupt protein function. The findings enhance our understanding of JOAG genetics and may aid in early diagnosis and therapeutic targeting.
Keywords: Genetics; Juvenile open-angle glaucoma; SIX6; Single nucleotide variation; Structural analysis.
© 2025. Japanese Ophthalmological Society.
Conflict of interest statement
Conflicts of interest: M. Yadav, None; S. Sachdeva, None; A. Yadav, None; A. Bhardwaj, None; V. Panghal, None; A. Kumari, None; R. Yadav, None; R. Kumar, None; M. Singh, None; S. Sharma, None; M. Tanwar, None.
Similar articles
-
Prevalence of Myocilin Mutations in a Cohort of Patients with Juvenile Open-Angle Glaucoma from sub-Saharan Africa.Ophthalmol Glaucoma. 2025 Apr 23:S2589-4196(25)00078-X. doi: 10.1016/j.ogla.2025.04.010. Online ahead of print. Ophthalmol Glaucoma. 2025. PMID: 40280414
-
Paucity of optineurin gene variants in Indian juvenile open-angle glaucoma patients.Indian J Ophthalmol. 2025 Aug 1;73(8):1181-1189. doi: 10.4103/IJO.IJO_1512_24. Epub 2025 Jul 28. Indian J Ophthalmol. 2025. PMID: 40719721
-
Long term follow-up on a juvenile open angle glaucoma pedigree with a novel EFEMP1 mutation (c.1313, p.Tyr438Cys).Ophthalmol Glaucoma. 2025 Aug 26:S2589-4196(25)00164-4. doi: 10.1016/j.ogla.2025.08.003. Online ahead of print. Ophthalmol Glaucoma. 2025. PMID: 40876537
-
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.Cochrane Database Syst Rev. 2017 Feb 23;2(2):CD010746. doi: 10.1002/14651858.CD010746.pub2. Cochrane Database Syst Rev. 2017. PMID: 28231380 Free PMC article.
-
Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.Cochrane Database Syst Rev. 2022 Jun 10;6(6):CD013817. doi: 10.1002/14651858.CD013817.pub2. Cochrane Database Syst Rev. 2022. PMID: 35686679 Free PMC article.
References
-
- Yadav M, Tanwar M. Impact of COVID-19 on glaucoma management: a review. Front Ophthalmol. 2022. https://doi.org/10.3389/fopht.2022.1003653 . - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous